4//SEC Filing
Weiland Robert J. 4
Accession 0001209191-18-036185
CIK 0001396814other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 8:11 PM ET
Size
5.2 KB
Accession
0001209191-18-036185
Insider Transaction Report
Form 4
Weiland Robert J.
Chief Commercial Officer
Transactions
- Sale
Common Stock
2018-06-04$33.02/sh−373$12,316→ 5,088 total
Footnotes (2)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- [F2]Includes 339 and 258 shares of common stock acquired under the issuer's employee stock purchase plan in June 2017 and December 2017, respectively.
Documents
Issuer
Pacira Pharmaceuticals, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001670648
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 8:11 PM ET
- Size
- 5.2 KB